Other News To Note

Friday, March 15, 2013

• GenSpera Inc., of San Antonio, said the FDA granted orphan drug designation to G-202 for the treatment of hepatocellular carcinoma.

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription

For Sales Inquiries,
http://clarivate.com/life-sciences/news/bioworld/#

NORTH AMERICA
Tel: +1-215-278-8411
Outside of the US
Tel. +44-20-3811-5317

clarivate.com
BioWorld.com	bioworldmedtech.com

Note: our contact information has changed

Customer Care: http://support.clarivate.com